[C:1]([O:5][C:6]([N:8]1[CH2:14][CH2:13][CH2:12][N:11]([C:15]2[CH:20]=[C:19]([N+:21]([O-])=O)[CH:18]=[CH:17][C:16]=2[O:24][CH3:25])[CH2:10][CH2:9]1)=[O:7])([CH3:4])([CH3:3])[CH3:2]>CO.[Pd]>[C:1]([O:5][C:6]([N:8]1[CH2:14][CH2:13][CH2:12][N:11]([C:15]2[CH:20]=[C:19]([NH2:21])[CH:18]=[CH:17][C:16]=2[O:24][CH3:25])[CH2:10][CH2:9]1)=[O:7])([CH3:4])([CH3:3])[CH3:2]4.5 g of 4-(5-nitro-2-methoxy-phenyl)-[1,4]diazepane-1-carboxylic acid tert-butyl ester (12.8 mmol) was dissolved in 40 mL of methanol, 1.36 g of 10% Pd/C was added and the mixture was hydrogenated under hydrogen gas for 4 h at 40° C. The reaction mixture was filtered over Celite and the filtrate evaporated to dryness in vacuo to yield 3.9 g of the title compound which was used in the next step without further purification.